chr17-3724251-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_031965.2(HASPIN):c.316C>T(p.Arg106Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,592,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031965.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HASPIN | NM_031965.2 | c.316C>T | p.Arg106Cys | missense_variant | 1/1 | ENST00000325418.5 | NP_114171.2 | |
ITGAE | NM_002208.5 | c.3085-507G>A | intron_variant | ENST00000263087.9 | NP_002199.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HASPIN | ENST00000325418.5 | c.316C>T | p.Arg106Cys | missense_variant | 1/1 | 6 | NM_031965.2 | ENSP00000325290.4 | ||
ITGAE | ENST00000263087.9 | c.3085-507G>A | intron_variant | 1 | NM_002208.5 | ENSP00000263087.4 | ||||
ITGAE | ENST00000570415.5 | n.479-507G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000565 AC: 12AN: 212360Hom.: 0 AF XY: 0.0000593 AC XY: 7AN XY: 117986
GnomAD4 exome AF: 0.0000465 AC: 67AN: 1440406Hom.: 0 Cov.: 71 AF XY: 0.0000405 AC XY: 29AN XY: 716760
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2023 | The c.316C>T (p.R106C) alteration is located in exon 1 (coding exon 1) of the GSG2 gene. This alteration results from a C to T substitution at nucleotide position 316, causing the arginine (R) at amino acid position 106 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at